Home

Welcome to the HealthTech Investor Days (HTID) by France Biotech.

A European business event under the High Patronage of Mr Emmanuel MACRON President of the French Republic and the support of the French Ministry for the Economy and Finance, Mr Bruno Le Maire.

For the first time, the European Life Sciences community is organizing a international business event to connect leading worldwide investors, pharmaceutical companies and European C-level executives innovative companies in HealthTech.

France Biotech has the ambition to make the city of Paris a European place for business meetings for international investors (European, American and Asian) and innovative HealthTech companies.

« Europe is a land of innovation in health with many start-up and SME’s looking for financing to make their innovations avalaible to patients and to meet the medical challenges of tomorrow. The objective of the HTID is to become a reference place for exchanges between European HealthTech companies, international investors and pharmaceutical groups », said Maryvonne Hiance, chairman of France Biotech

Meet us on June 24th & 25th 2019

About the event

This HealthTech Investor Days, a European Business event, will take place in Paris on June 24th & 25th , under the High Patronage of Mr Emmanuel MACRON President of the French Republic and the support of the French Ministry for the Economy and Finance, Mr Bruno Le Maire. 

The two-day event will feature thematic panel discussion and one-on-one metings intented for European HealthTech companies, worldwide investors and pharmaceutical companies.

European targeted companies:
This event is organized for private and listed European companies willing to address leading investors and looking to raise funds.

The HTID is targeting :

  • European listed innovative companies in HealthTech (biotech, medtech, digital-health) with a market-cap starting from around €20 million
  • An on-going Phase II minimum for private biotech companies
  • CE or FDA approved product for medtech companies

If your project meets our requirements, please complete our dedicated application form  to submit an expression of interest.

This event takes place at the Peninsula Paris and includes:

  • Investors one-on-one meetings between innovative HealthTech companies and investors: French, European, American, Asian hedge funds, VC, banks for near and long-term investment;
  • Partnering one-on-one meetings with pharmaceuticals companies such as Servier, Sanofi , Ipsen, Guerbet, Pfizer, Takeda, Amgen …;
  • Conferences and thematic panel discussions on specific topics supervised by well-known international scientific Key Opinion Leaders;
  • Networking events with special guests on Monday and Tuesday evening.

More information: Contact us HERE

Contacts

Sophie Villedieu – France Biotech
Business Manager & US Communications
+33 (0)6 64 27 32 25
sophie.villedieu@france-biotech.org

With the assistance of Nathalie Donne in the organization
Nathalie Donne – Shape N Link
Co-founder and partner 
+33 (0) 6 67 67 44 97
nathalie.donne@shapenlink.com

Media contacts:
EUROPE:
Caroline Carmagnol / Tatiana Vieira – Alize RP 
+ 33 (0)1 44 54 36 66 / + 33 (0)6 31 13 76 20
francebiotech@alizerp.com

NORTH AMERICA:
Marion Janic / Kate Barrette – RooneyPartners LLC
+1.212.223.4017 / +1.212.223.0561 
mjanic@rooneyco.com / kbarrette@rooneyco.com

This event has been supervised by Maryvonne Hiance, Chairman of FRANCE BIOTECH and Vice President OSE IMMUNOTHERAPEUTICS